| PCRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PCRX shares outstanding history going back to 2/2/2011:
Also see: PCRX Market Cap History PCRX YTD Return |
PCRX Shares Outstanding History — Pacira Pharmaceuticals Share Count Over Time
As of 8/3/2026 Pacira Pharmaceuticals has 39.86 million PCRX shares outstanding. Investors often track the PCRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PCRX share count trends over time, with 64 historical shares outstanding datapoints presented, dating back to 2/2/2011.
| PCRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCRX Historical Shares Outstanding: +6.55% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PCRX Stock Price Chart |
| About Pacira BioSciences Inc |
| Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. Co.'s non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. We show 64 historical shares outstanding datapoints in our coverage of PCRX's shares outstanding history. Understanding the changing numbers of PCRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PCRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PCRX by allowing them to research PCRX shares outstanding history as well as any other stock in our coverage universe. |
| PCRX Current Stock Quote |
Quotes delayed 20 minutes  Free PCRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| PCRX Share Performance |
| Shares Outstanding Peers |
| Pacira Pharmaceuticals (PCRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PCSA Shares Outstanding History PCVX Shares Outstanding History PDCO Shares Outstanding History PDEX Shares Outstanding History PDSB Shares Outstanding History PEN Shares Outstanding History PEPG Shares Outstanding History PETV Shares Outstanding History PETX Shares Outstanding History PFE Shares Outstanding History More Healthcare companies » |
PCRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
